India
Mirae Asset Venture Opportunity Fund II, has a target of Rs 1,800 crore ($188m)
1
US to tell partners they must choose sides in AI race with China
2
V3 Ventures leads $3m funding in Scrubsy, and other India deals
3
Editor's take: The week that was — Aug 10-15
4
Stonepeak’s second Asia infra fund reaches 50% of target corpus
5
Brookfield forays into Japan housing market with $627m deal
More Stories
Beyond the Buyout: India’s hospital gold rush has a valuation problem
SE Asia Deal Review: Startup funding falls 84% in July after June’s surge
How much did impact investor Lightrock make from Kauvery Hospitals exit?
Editor’s take: The week that was — Aug 10-15
The fund is part of a $3.5b global fundraising exercise across four vehicles.
Greater China
The Series B round brings Aureka’s total funding since inception to nearly $200m.
The 26 megadeals raised a combined $8.4 billion, or 71.9% of the monthly financing.
The firm is targeting a total corpus of Rs 750 crore.
Singapore
The new investor was joined by existing investor Odyssey Therapeutics in the round.
The US startup emerged from stealth two years after it was founded.
The fresh capital will help the startup expand into new markets and invest in supply chain and technology.
The round was backed by Vertex Ventures Southeast Asia & India and Vertex Growth.
Big-cheque financing in AI and embodied intelligence reached new heights.
